Stock Earnings

Question 1

What are Oryzon Genomics SA's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Oryzon Genomics SA has a total asset of $108, Net loss of $-3

Question 2

What are the key financial ratios for ORYZF?

Accepted Answer

Oryzon Genomics SA's Current ratio is 5.14, has a Net margin is 0, sales per share of $0.

Question 3

How is Oryzon Genomics SA's revenue broken down by segment or geography?

Accepted Answer

Currently Oryzon Genomics SA data is not available.

Question 4

Is Oryzon Genomics SA profitable?

Accepted Answer

no, according to the latest financial statements, Oryzon Genomics SA has a net loss of $-3

Question 5

Does Oryzon Genomics SA have any liabilities?

Accepted Answer

yes, Oryzon Genomics SA has liability of 21

Question 6

How many outstanding shares for Oryzon Genomics SA?

Accepted Answer

Oryzon Genomics SA has a total outstanding shares of 64.74

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	1	1	2	3	0
Gross Profit	0	-1	-1	-2	-3	0
Selling, General & Admin	4	3	3	3	3	3
Research & Development	--	--	--	--	--	--
Operating Expenses	4	3	3	3	3	3
Other Non Operating Income (Expenses)	0	--	--	--	--	--
Pretax Income	-5	-5	-6	-6	-7	-4
Income Tax Expense	-1	-1	-2	-2	-2	-1
Net Income	-4	-3	-3	-4	-4	-3
Net Income Growth	33%	0%	-25%	0%	33%	0%
Shares Outstanding (Diluted)	90.27	64.74	60.87	55.29	52.76	52.76
Shares Change (YoY)	41%	6%	10%	5%	0%	16%
EPS (Diluted)	-0.06	-0.05	-0.05	-0.07	-0.09	-0.06
EPS Growth	8%	3%	-28%	-15%	50%	-25%
Free Cash Flow	-10	-13	-15	-16	-15	-14
Free Cash Flow Per Share	-0.11	-0.2	-0.24	-0.28	-0.28	-0.26
Gross Margin	0%	0%	0%	0%	0%	0%
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-4	-4	-4	-5	-7	-4
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-4	-4	-4	-5	-7	-4
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	20%	20%	33.33%	33.33%	28.57%	25%

Oryzon Genomics SA (ORYZF) Price